Acceptability of a Novel Levofloxacin Dispersible Tablet Formulation in Young Children Exposed to Multidrug-resistant Tuberculosis. (2019)

First Author: Purchase SE

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/inf.0000000000002268

PubMed Identifier: 30550511

Publication URI: http://europepmc.org/abstract/MED/30550511

Type: Journal Article/Review

Volume: 38

Parent Publication: The Pediatric infectious disease journal

Issue: 6

ISSN: 0891-3668